Clinically Proven to Significantly Reduce
or Even Eliminate Chemo Nail Damage
At Polybalm, we believe in evidence-based solutions. That’s why our formula has undergone rigorous clinical trials to ensure its effectiveness and safety.
The Polybalm Clinical Trials*
In a published 2018 clinical trial, Polybalm was shown to significantly reduce nail damage caused by chemotherapy.
About the Study
The randomized, double-blind, placebo-controlled study followed cancer patients through treatment. Those using Polybalm so visibly stronger, healthier nails than those using a placebo.
✔ Polybalm Group – Applied the botanical-based balm to their nails.
✔ Placebo Group – Used a non-active balm for comparison.
Researchers monitored nail strength, appearance, and discomfort throughout treatment.
Key Findings
-
Significant Nail Protection: Patients using Polybalm experienced significant improvement, less nail breakage, discoloration, and pain than those using the placebo.
-
100% Natural & Safe Formula: The botanical ingredients provided a gentle and effective solution without major side effects.
-
Improved Quality of Life: Healthier nails helped patients feel more comfortable and confident during chemotherapy.
Why This Matters:
For patients: Polybalm is a safe, proven way to protect nail health during chemo..
For providers: Clinical evidence supports its use in cancer care plans.
Clinical Evidence & Research
The Polybalm Clinical Trial (2018)
The study was conducted over two years with 61 patients undergoing chemotherapy for breast and prostate cancer.
✔ Polybalm® Group: 29 out of 30 patients (97%) experienced virtually no nail damage.
❌ Placebo Group: More than half experienced significant nail deterioration.
⚠ No adverse effects were reported with either balm.
Clinical Trial: Proven Protection for Nails!
A rigorous clinical trial conducted at Cambridge University-affiliated hospitals tested Polybalm’s effectiveness in preventing chemotherapy-related nail damage.
Trial Design
📌 Participants: 61 patients undergoing chemotherapy for breast or prostate cancer.
📌 Method: Patients were randomly assigned (50:50) to use either:
✔ Polybalm® – A plant-based nail balm.
✔ Placebo – A simple petroleum-based moisturizer.
📌 Assessment: Nail health was evaluated by patients, physicians, and independent reviewers using validated scoring tools and photographs.
Results
✅ Polybalm® Group: Virtually no nail damage in 29 out of 30 patients. Some even reported improved nail quality.
❌ Placebo Group: More than half experienced significant nail damage and distress.
⚠ No adverse reactions were reported with either balm.
Conclusion
The polyphenol-rich formula in Polybalm® significantly reduced chemotherapy-related nail damage, improving comfort and quality of life. This groundbreaking trial provides strong evidence that Polybalm® is a safe, effective solution for protecting nails during cancer treatment.
Powered by Nature. Proven by Science.
Polybalm 100% natural, plant-based ingredients selected for their protective, nourishing and healing properties plus their anti-fungal, antibacterial and antimicrobial benefits - without harsh chemicals. It's gentle, effective care for nails under stress from cancer treatments.
.
Expert Insights:
Dr. Thomas on Polybalm
Hear directly from Dr. Robert Thomas, oncologist and lead researcher of the Polybalm Clinical Trial, as he discusses the science behind Polybalm and its benefits for chemotherapy patients.
🎥 Watch the video to learn:
✅ How Polybalm helps protect nails during chemotherapy
✅ The key findings of the 2018 clinical trial
✅ Why healthcare professionals and patients trust Polybalm
"Our research has shown that Polybalm provides a natural, safe, and effective way to prevent chemotherapy-induced nail damage." – Doctor Robert Thomas